1921
Volume 5, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Summary

Glaucarubin, a crystalline glycoside isolated from and found to have amebicidal properties in vitro and in experimental animal amebiasis, was evaluated in the treatment of the human infection. Cure rates in the order of 70 per cent were observed following treatment by mouth for 10 days with daily doses of 5 mg./kg. (maximum daily dose 300 mg.). With the exception of vomiting in 2 patients and a transitory decrease in leucocyte count in another, the drug was well tolerated in 113 patients.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1956.5.501
1956-05-01
2017-09-23
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1956.5.501
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error